John Reader
Founder bei SAREUM HOLDINGS PLC
Vermögen: 146 272 $ am 31.03.2024
Profil
John Charles Reader is the founder of Sareum Holdings Plc, which was founded in 2003.
He is currently the Executive Director & Chief Scientific Officer at Sareum Holdings Plc.
Dr. Reader's former jobs include being an Associate Director at Cambridge Discovery Chemistry, Pharmacopeia, Inc., and Millennium Pharmaceuticals Research & Development Ltd.
He was also a Member at The Engineering & Physical Sciences Research Council.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SAREUM HOLDINGS PLC
1,50% | 28.03.2024 | 1 077 111 ( 1,50% ) | 146 272 $ | 31.03.2024 |
Aktive Positionen von John Reader
| Unternehmen | Position | Beginn |
|---|---|---|
| SAREUM HOLDINGS PLC | Founder | 01.08.2003 |
Ehemalige bekannte Positionen von John Reader
| Unternehmen | Position | Ende |
|---|---|---|
Cambridge Discovery Chemistry
 Cambridge Discovery Chemistry Miscellaneous Commercial ServicesCommercial Services Part of Signature BioScience, Inc., Cambridge Discovery Chemistry provides chemistry research services. Cambridge Discovery Chemistry was acquired by Signature BioScience, Inc. from Millennium Pharmaceuticals, Inc. on July 16, 2001. | Corporate Officer/Principal | - |
| Millennium Pharmaceuticals Research & Development Ltd. | Corporate Officer/Principal | - |
| Pharmacopeia, Inc. /Old/ | Corporate Officer/Principal | - |
The Engineering & Physical Sciences Research Council
 The Engineering & Physical Sciences Research Council Miscellaneous Commercial ServicesCommercial Services The Engineering & Physical Sciences Research Council provides funds for research and training in engineering and the physical sciences. It covers range of subjects from mathematics to material science and from information technology to structural engineering. The firm offers services to the users and beneficiaries of chemical, communications, construction, electrical, electronic, energy, engineering, information technology, pharmaceutical, process and other industries. The company was founded in 1994 and is headquartered in Swindon, the United Kingdom. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SAREUM HOLDINGS PLC | Miscellaneous |
| Private Unternehmen | 4 |
|---|---|
Cambridge Discovery Chemistry
Cambridge Discovery Chemistry Miscellaneous Commercial ServicesCommercial Services Part of Signature BioScience, Inc., Cambridge Discovery Chemistry provides chemistry research services. Cambridge Discovery Chemistry was acquired by Signature BioScience, Inc. from Millennium Pharmaceuticals, Inc. on July 16, 2001. | Commercial Services |
| Pharmacopeia, Inc. /Old/ | Commercial Services |
The Engineering & Physical Sciences Research Council
The Engineering & Physical Sciences Research Council Miscellaneous Commercial ServicesCommercial Services The Engineering & Physical Sciences Research Council provides funds for research and training in engineering and the physical sciences. It covers range of subjects from mathematics to material science and from information technology to structural engineering. The firm offers services to the users and beneficiaries of chemical, communications, construction, electrical, electronic, energy, engineering, information technology, pharmaceutical, process and other industries. The company was founded in 1994 and is headquartered in Swindon, the United Kingdom. | Commercial Services |
| Millennium Pharmaceuticals Research & Development Ltd. |
